跳至主要内容
临床试验/IRCT138811103210N2
IRCT138811103210N2已完成2 期

Comparison of Lorazepam and Zolpidem effect on insomnia in bone marrow trasplantation patients

Vice chancellor for research,Faculty of pharmcy, Shaheed Beheshti University of Medical Sciences0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Bone marrow transplantation patients that have insomnia base on the
  • SleepMed Insomnia Index questionnaire; Patients in range of 18-65 years old. Exclusion criteria: Sensitivity to Lorazepam or Zolpidem; Narrow-angle glaucoma; Pregnancy & breast feeding; Hepatic encephalopathy; Rising of hepatic enzymes ( AST, ALT, ALP, LDH ) 3 times the upper limit of normal; Serum creatinine concentration more than 2.5 mg/dl; Use of alcohol; Patients who have no remission in insomnia after taking 4 mg Lorazepam or 10 mg Zolpidem during 4 days; Addiction to opioids

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research,Faculty of pharmcy, Shaheed Beheshti University of Medical Sciences

相似试验